Brandywine Global Investment Management’s BIO-REFERENCE LABS INC-NEW- BRLI Stock Holding History

Brandywine Global Investment Management’s Portfolio BRLI Stock Details BRLI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-71,715	Closed	-$2.96M	–	1076
2015 Q2	$2.96M	Sell	71,715 -176,064	-71%	-$6.31M	0.02%	537
2015 Q1	$8.73M	Sell	247,779 -137,073	-36%	-$4.64M	0.06%	315
2014 Q4	$12.4M	Sell	384,852 -27,234	-7%	-$788K	0.08%	221
2014 Q3	$11.6M	Buy	412,086 +73,984	+22%	+$2.25M	0.09%	214
2014 Q2	$10.2M	Buy	338,102 +36,664	+12%	+$1.01M	0.08%	223
2014 Q1	$8.35M	Buy	+301,438	New	+$7.89M	0.07%	251

Other funds holding BRLI

SAM

Shell Asset Management The Hague, Netherlands $996M AUM 26.19% 1-Year Est. Return

Brandywine Global Investment Management's BRLI Position: Q3 2015 in Review

Brandywine Global Investment Management sold out of BIO-REFERENCE LABS INC-NEW- (BRLI) in Q3 2015, closing a stake of 71,715 shares — an estimated $2.96M sold.

Brandywine Global Investment Management first reported a position in BRLI in Q1 2014 and held it in 6 quarters. The position peaked at $12.4M in Q4 2014. 1 fund tracked by Wall St. Rank holds BRLI as of Q3 2015.

Brandywine Global Investment Management reported no remaining BIO-REFERENCE LABS INC-NEW- position as of Q3 2015 after selling out during the quarter.
Brandywine Global Investment Management sold 71,715 BIO-REFERENCE LABS INC-NEW- shares in Q3 2015, an estimated $2.96M.
Brandywine Global Investment Management first reported a position in BIO-REFERENCE LABS INC-NEW- in Q1 2014 and held it in 6 quarters.
Brandywine Global Investment Management's BIO-REFERENCE LABS INC-NEW- position peaked at $12.4M in Q4 2014.
1 fund tracked by Wall St. Rank held BIO-REFERENCE LABS INC-NEW- as of Q3 2015.

Based on Brandywine Global Investment Management's 13F filing for Q3 2015, filed 16 Nov 2015.